Use of statins in patients receiving oral blood glucose-lowering drugs

Norsk Epidemiologi

Volumn 18, Issue 2, 2008, Pages 191-194

  Strøm, Hanne ^a   Sakshaug, Solveig ^a   Skurtveit, Svetlana ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DATA BASE; FEMALE; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; SEX DIFFERENCE; SEX RATIO;

EID: 45549091496     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570-81.
2. Haffner SM et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. NEJM 1998; 339: 229-34.
3. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371: 117-25.
4. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007; 28: 88-136.
5. Terapianbefalinger: behandling av hyperlipidemi. SLK-publikasjon 2000: 6. Oslo: Statens legemiddelkontroll, 2000.
6. Strøm H. Reseptbasert legemiddelregister: Et viktig verktøy for å oppnå detaljert legemiddelstatistikk. Norsk Epidemiologi 2004; 14: 53-55.
7. WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs 2008. Oslo, 2007.
8. Strøm H et al. Hvor mange og hvem behandles medikamentelt for diabetes mellitus? Tidsskr Nor Lægeforen 2006; 126: 768-70.
9. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-8.
10. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-8.
11. Dunaif A. Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome - a reappraisal. Nat Clin Pract Endocrinol Metab 2008; 4: 272-83.
12. Claudi T, Birkeland K, Jensen T. Statiner og diabetes - indikasjoner og refusjonsregler. Tidsskr Nor Lægeforen 2003; 123: 1564-5.
13. Schramm TK et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008; 117: 1945-54.